Bookmark

Add to MyYahoo RSS

SanofiSynthlabo News

News on SanofiSynthlabo (Ticker: SNY) continually updated from thousands of sources around the net.

6 hrs ago | Sys-Con Media

Upcoming Event, Positive Findings, Regulatory Approvals, and Vaccine...

Today, Analysts Review released its research reports regarding WellPoint Inc. , Tekmira Pharmaceuticals Corporation , Zoetis Inc. , Sanofi SA and GlaxoSmithKline plc .

Comment?

Related Topix: Wellpoint Health Networks, Insurance, Tekmira Pharmaceuticals, Biotech, Medicine, Genzyme General, Healthcare Industry, GlaxoSmithKline, US News, United States Department of Agriculture

Tue Aug 26, 2014

AmericanBankingNews.com

Sanofi SA Reaches New 52-Week High at $54.95

Sanofi SA reached a new 52-week high during mid-day trading on Tuesday , Analyst Ratings Net reports.

Comment?

Related Topix: Biotech

Seeking Alpha

Why I Bought Into Monday's Move In Regeneron

Valuation may explain why there is a decent short position on the stock, but the shorts may be getting uncomfortable now.

Comment?

Related Topix: Biotech, Semco Energy, Medicine, Genzyme General, Energy, Origin Healthcare Solutions, Acambis, Healthcare Industry, Regeneron Pharmaceuticals

Mon Aug 25, 2014

Benzinga

The 4 Companies Teaming Up For A New Tool To Fight Cancer

Big pharma and one relatively small company are teaming up to develop a master test that will help doctors pick a combination of drugs tailored to the individual patient's condition.

Comment?

Related Topix: Biotech, Medicine, Cancer, Health, Johnson and Johnson, Healthcare Industry, Genetics, Veracode, Scientific Instruments, Illumina

Thu Aug 21, 2014

Investor's Business Daily

Illumina lines up key partners

Illumina shares fell0.5% to 172.09. AstraZeneca rose 3.1% to 73.19 and Sanofi rose 1.8% to 53.74.

Comment?

Related Topix: Biotech, Semco Energy, Medicine, Genzyme General, Energy, Origin Healthcare Solutions, Acambis, Healthcare Industry

Wed Aug 13, 2014

SchaeffersResearch.com

Option Bulls Active as InterMune Inc (ITMN) Soars On Buyout Buzz

InterMune Inc has tacked on 13.7% this afternoon to trade at $51.74, after earlier notching a decade-plus high of $54.57.

Comment?

Related Topix: Biotech, InterMune, Medicine, Healthcare Industry, Semco Energy, Genzyme General, Energy, Origin Healthcare Solutions, Acambis

Benzinga

's M&A Chatter for Wednesday August 13, 2014

The Rumor : Shares of Intermune spiked sharply higher Wednesday, on a report from Bloomberg that Sanofi and Roche had submitted bids for the Brisbane, CA-based biotech company, according to sources.

Comment?

Related Topix: Biotech, InterMune, Medicine, Healthcare Industry, San Mateo County, CA, Brisbane, CA, Goldman Sachs, Investment Services, Financial Services, Beverages, Constellation Brands

GuruFocus.com

There is a Tide in the Affairs of MannKind: When Taken At the Flood, Will Lead to Fortune

Disclosure: I am long on MannKind. Introduction On August 11, 2014, investors witnessed MannKind's partnership announcement stating the company has entered into collaboration and a licensing agreement with Sanofi SA .

Comment?

Related Topix: Biotech, Semco Energy, Medicine, Genzyme General, Energy, Origin Healthcare Solutions, Acambis, Healthcare Industry, Insulin (generic), Humulin, Novolin

Mon Aug 11, 2014

Seeking Alpha

Why The Sanofi Deal Is The Best Possible Deal For MannKind Investors

The suspense is over. As reported by Bloomberg ,"French insulin maker Sanofi will "pay $150 million up front and as much as $775 million if the drug, Afrezza, meets certain sales and development targets."

Comment?

Related Topix: Biotech, Medicine, Insulin (generic), Humulin, Novolin, MannKind, Valencia, CA, Diabetes, Health, Marketing

Seeking Alpha

Sanofi Appears To Be In The Early Stages Of An Earnings Rebound

Sanofi , the subject of this article, is one of the oldest and largest pharmaceutical concerns in the world, competing in the same league as world-class enterprises Novartis , Pfizer , Glaxo , and Merck .

Comment?

Related Topix: Biotech, Medicine, Genzyme General, Healthcare Industry, Pfizer, Novartis, Merck

Business Journal

Requiem for a son: Voucher program speeds drugs aimed at childhood diseases

Brain cancer killed Nancy Goodman 's 10-year-old son Jacob, but no one was happier than Goodman when Regeneron Pharmaceuticals Inc. and Sanofi SA asked the Food and Drug Administration for speedy approval of a cholesterol-fighting drug.

Comment?

Related Topix: Biotech, Medicine, Regeneron Pharmaceuticals, Healthcare Industry, Healthcare Law, Law, Food and Drug Administration, Semco Energy, Energy, Acambis

Fri Aug 08, 2014

AmericanBankingNews.com

Sanofi SA Given Consensus Rating of "Hold" by Analysts

Sanofi SA has earned an average rating of "Hold" from the ten ratings firms that are presently covering the stock, Analyst RN reports .

Comment?

Related Topix: Biotech

Thu Aug 07, 2014

Seeking Alpha

Sanofi: Confronting Lantus Patent Expiry With More Efficient Successor Toujeo

Sanofi received the US FDA's acceptance for reviewing its New Drug Application for investigational basal insulin, Toujeo.

Comment?

Related Topix: Biotech, Medicine, Lantus, Insulin Glargine (generic), Insulin (generic), Humulin, Novolin, Healthcare Law, Food and Drug Administration, Law, Eli Lilly, Healthcare Industry

GlobeNewswire

Sanofi Licenses Immune Design's GLAAS Platform to Explore Novel Approach to Treat Food Allergy

Sanofi and Immune Design , a clinical-stage immunotherapy company, today announced that they have entered into a licensing agreement for use of Immune Design's GLAASTM discovery platform to develop therapeutic agents to treat a selected food allergy.

Comment?

Related Topix: Biotech, Allergy, Health, Genzyme General, Healthcare Industry, Immunology, Biology, Science, Infectious Diseases

Mon Aug 04, 2014

AmericanBankingNews.com

Sanofi SA Receives Average Recommendation of "Hold" from Brokerages

Shares of Sanofi SA have been given a consensus recommendation of "Hold" by the eleven ratings firms that are covering the stock, StockRatingsNetwork.com reports .

Comment?

Related Topix: Biotech

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••